Invesco
VERA icon

Invesco’s Vera Therapeutics VERA Stock Holding History

Invesco’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Sell
50,847
-7,867
-13% -$293K ﹤0.01% 2544
2026
Q1 		$2.36M Sell
58,714
-31,137
-35% -$1.34M ﹤0.01% 2471
2025
Q4 		$4.55M Buy
89,851
+59,219
+193% +$2.1M ﹤0.01% 2279
2025
Q3 		$890K Buy
30,632
+2,785
+10% +$64.4K ﹤0.01% 2986
2025
Q2 		$656K Buy
27,847
+550
+2% +$12.4K ﹤0.01% 3049
2025
Q1 		$656K Buy
27,297
+5,343
+24% +$172K ﹤0.01% 3039
2024
Q4 		$928K Buy
21,954
+1,444
+7% +$63.9K ﹤0.01% 2948
2024
Q3 		$907K Buy
20,510
+1,754
+9% +$66.6K ﹤0.01% 2947
2024
Q2 		$679K Sell
18,756
-288,854
-94% -$11.5M ﹤0.01% 3145
2024
Q1 		$13.3M Buy
307,610
+37,248
+14% +$1.33M ﹤0.01% 1661
2023
Q4 		$4.16M Sell
270,362
-120,419
-31% -$1.53M ﹤0.01% 2332
2023
Q3 		$5.36M Buy
390,781
+116,171
+42% +$1.99M ﹤0.01% 2168
2023
Q2 		$4.41M Buy
+274,610
New +$2.48M ﹤0.01% 2308

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco's VERA Position: Q2 2026 in Review

Invesco reduced its Vera Therapeutics (VERA) stake by 13% in Q2 2026, selling an estimated $293K and leaving 50,847 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

Invesco first reported a position in VERA in Q2 2023 and has held it in 13 quarters since. The position peaked at $13.3M in Q1 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Invesco held 50,847 shares of Vera Therapeutics worth $2.18M as of Q2 2026.
  • Invesco sold 7,867 Vera Therapeutics shares in Q2 2026, an estimated $293K.
  • Vera Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2544 holding.
  • Invesco first reported a position in Vera Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Invesco's Vera Therapeutics position peaked at $13.3M in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.